NeuroBo - NRBO Net Assets per Single Share
NeuroBo Pharmaceuticals (NRBO) relies on external contractors for its production capacities to develop drugs for metabolic disorders. The company's book value per share visualizes equity dynamics, where 1.49 forms the current metric. The strategy is based on liver protection during the fight against obesity, while management focuses on FDA tests, considering the influence of a major Korean owner.
%20-%20Net%20Asset%20Value%20per%20Share&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_NRBO_-_NeuroBo-Pharmaceuticals_-_Net-Asset-Value-per-Share "NRBO (NeuroBo Pharma) Net Assets per Single Share history from 07/04/2022 to 12/07/2024 | 👁️GURU.Markets👁️")
neurobopharma.com - analytical breakdowns and key metrics (NRBO)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Equity Ratio NeuroBo Pharmaceuticals|NRBO - Long-Term Debt to Capital|Short-Term Debt to Equity NeuroBo Pharmaceuticals, Inc.|NRBO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio NeuroBo Pharmaceuticals, Inc.|NRBO - Long-Term Debt|Company Short-Term Debt NeuroBo Pharmaceuticals
Fundamental company valuation:NeuroBo, NRBO
An investment audit of the issuer requires an analysis of equity divided by the number of shares outstanding, which allows for the determination of the real value of the business stake excluding market speculation. For NeuroBo Pharmaceuticals (NRBO), which is expanding through R&D partnerships with its parent holding company without external M&A, the historical book value per share serves as an indicator of financial stability and the efficiency of internal resource accumulation.
Competitor analysis for NeuroBo Pharmaceuticals
BIIB - Book Value per Share|NBIX: Net Assets per Single Share|Net Assets per Single Share RGC|AXSM (axsome.com) - Net Asset Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines (PRAX)|Equity per Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share Prothena Corporation PRTA|Accounting Value per Share ALEC (Alector)|Annexon Biosciences Inc. - Book Value per Share|Net Assets per Single Share Omeros Corp. (OMER)|NGNE: Accounting Value of a Share|Net Assets per Single Share ACIU|Voyager Therapeutics Inc (VYGR) - Net Asset Value per Share|Book Value per Share Neumora Therapeutics Inc|Net Assets per Single Share SCLX|Tevogen Bio Holdings - Net Assets per Single Share|Net Asset Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Inhibikase Therapeutics Inc - Accounting Value of a Share|Net Assets per Single Share Cassava|ASRT - Share Book Value|Book Value per Share coyatherapeutics.com COYA|Vistagen (VTGN) - Accounting Value of a Share|OVID (Ovid Therapeutics Inc) - Book Value per Share|Book Value per Share ABOS|CervoMed Inc (CRVO) - Net Assets per Single Share|Accounting Value of a Share ATHE (alteritytherapeutics.com)|Clene - Net Assets per Single Share|Accounting Value per Share PepGen Inc PEPG|Jupiter Neurosciences Inc - Book Value per Share|RLMD - Book Value per Share|ANVS (Annovis Bio Corp) - Book Value per Share|Grace Therapeutics (GRCE) - Accounting Value per Share|Book Value per Share AIFF (Firefly Neuroscience, Inc)|Net Asset Value per Share ANEW Medical, Inc. (KLTO)|Accounting Value per Share NRSN|Book Value per Share Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Value per Share MetaVia (MTVA)|Book Price of a Share NeurAxis Inc NRXS|Book Value per Share HSDT (Helius Medical Technologies Inc.)|PASG - Net Assets per Share|NEUP (bionomics.com.au) - Book Value per Share|Minerva Neurosciences Inc (NERV) - Accounting Value per Share|ATHA (Athira) - Book Value per Share|Book Value per Share ADXN|Net Assets per Single Share Alzamend Neuro, Inc. (ALZN)|Net Assets per Single Share CYCN (cyclerion.com)|Net Assets per Single Share PTIX|Pasithea Therapeutics Corp - Net Assets per Share|Cortigent Medical (CRGT) - Net Assets per Single Share|ATXI: Equity per Share|Net Assets per Single Share Brainstorm Cell BCLI|caratherapeutics.com (CARA) - Accounting Value of a Share|Book Value per Share Chromocell Therapeutics Corp.|Net Assets per Single Share ELYM|Intra-Cellular Therapies - Net Assets per Single Share|Net Asset Value per Share LBPH (Longboard)|MRNS - Net Assets per Single Share|Equity per Share nkgenbiotech.com NKGN|SAGE (Sage Therapeutics) - Book Value per Share|Synaptogenix Inc. (SNPX) - Net Asset Value per Share|TRVN: Accounting Value per Share|VIGL (Vigil Neuroscience, Inc.) - Book Value per Share|WENA - Net Assets per Single Share|Accounting Value of a Share CERE